Story Poster
Notre Dame Football Recruiting

2026 DL Dominic Funke Enjoys Another Notre Dame Visit

April 30, 2023

Dominic Funke‍ was back at Notre Dame last weekend for the Irish’s spring game.

The 2026 Massachusetts defensive lineman, who visited South Bend twice last summer, has early scholarship offers from Boston College, Rutgers, Temple, and Pitt.

The 6-foot-3, 210-pounder had a fantastic time during his most recent visit.

"It went really well,” Funke said. “I had a great time. I loved it."

During the trip, Funke got another peek inside the Irish Football program.

"We got to sit in on the team meetings for a little bit and Coach (Marcus) Freeman gave a great speech about the Notre Dame education and how great it is," Funke said. "It was inspiring. It was just a great speech."

He also got to watch practice, which he described as "really cool” and see how defensive line coach Al Washington runs his unit.

The St. Sebastian’s School standout had some productive conversations with the coaches, including Freeman, Washington and defensive coordinator Al Golden.

"They're all really good guys and they seem to be interested in me and I'm definitely interested in Notre Dame," he said, adding the coaches seem to like his style of play and his high ceiling.

Funke was again impressed with Notre Dame's campus. He also had the opportunity to meet other visiting recruits.

"A lot of really good dudes,” he said. “A lot of dudes who I will keep in touch with.

He also enjoyed the Blue-Gold Game.

"It was super fun to watch,” he said. “I loved it.

“The intensity and how much the fans really loved it. The whole culture around Notre Dame football, like how everyone cares so much about it and it means so much to people. From the players, the fans to the leprechaun, everyone's into it. It was awesome.

"I think I like Notre Dame now even more than I already did."

Under Armour Navy Fighting Irish HOVR Sonic 5 Running Shoes ($119.99)

subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.